BAM
LJPC

Brave Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Brave Asset Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-600
Closed -$11K – 458
2015
Q1 		$11K Sell
600
-1,200
-67% -$24.3K 0.01% 357
2014
Q4 		$33K Hold
1,800
– – 0.02% 263
2014
Q3 		$17K Hold
1,800
– – 0.01% 316
2014
Q2 		$17K Buy
+1,800
New +$16.4K 0.01% 324

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Brave Asset Management's LJPC Position: Q2 2015 in Review

Brave Asset Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2015, closing a stake of 600 shares — an estimated $11K sold.

Brave Asset Management first reported a position in LJPC in Q2 2014 and held it in 4 quarters. The position peaked at $33K in Q4 2014. 53 funds tracked by Wall St. Rank hold LJPC as of Q2 2015.

  • Brave Asset Management reported no remaining La Jolla Pharmaceutical Company position as of Q2 2015 after selling out during the quarter.
  • Brave Asset Management sold 600 La Jolla Pharmaceutical Company shares in Q2 2015, an estimated $11K.
  • Brave Asset Management first reported a position in La Jolla Pharmaceutical Company in Q2 2014 and held it in 4 quarters.
  • Brave Asset Management's La Jolla Pharmaceutical Company position peaked at $33K in Q4 2014.
  • 53 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2015.

Based on Brave Asset Management's 13F filing for Q2 2015, filed 11 Aug 2015.